00314.HK
Sipai Health Technology Co., Ltd.
HKSE · Healthcare · Medical - Healthcare Plans · CN
HKD 1.57
+1.62%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.4B | 2.0B | 4.6B | 4.7B | 4.1B |
| Cost of Revenue | 3.1B | 1.7B | 4.2B | 4.3B | 3.8B |
| Gross Profit | 332.7M | 277.1M | 386.4M | 414.7M | 337.4M |
| Operating Expenses | |||||
| R&D Expense | 12.3M | 9.9M | 22.3M | 45.9M | 62.6M |
| SG&A Expense | 566.0M | 358.3M | 602.3M | 640.1M | 907.9M |
| General & Admin Expense | 312.6M | — | 324.0M | 347.8M | 575.0M |
| Selling & Marketing Expense | 221.4M | — | 278.4M | 292.3M | 332.9M |
| Other Expenses | — | 10.5M | 41.4M | 10.0M | 5.5M |
| Total Operating Expenses | 578.4M | 378.8M | 666.0M | 696.0M | 976.0M |
| Cost and Expenses | 3.7B | 2.1B | 4.8B | 5.0B | 4.8B |
| Operating Income (EBIT) | (248.3M) | (101.7M) | (279.6M) | (283.6M) | (633.1M) |
| Non-Operating | |||||
| Interest Income | 4.1M | 8.1M | 15.8M | 31.3M | 17.2M |
| Interest Expense | 847.0K | 1.4M | 3.1M | 3.5M | 4.0M |
| Net Interest Income | 3.2M | 6.7M | 12.8M | 27.9M | 13.2M |
| Other Non-Op Income/Expense | (119.6M) | (23.1M) | (81.1M) | 37.9M | (726.4M) |
| Non-Operating Income (excl Interest) | 16.7M | — | 78.0M | (3.9M) | 751.4M |
| EBT (Pre-Tax Income) | (367.9M) | (124.8M) | (360.6M) | (245.7M) | (1.4B) |
| Income Tax Expense | 2.9M | (1.3M) | 1.2M | 1.0M | 3.3M |
| Bottom Line | |||||
| Net Income | (317.5M) | (121.1M) | (323.7M) | (255.8M) | (1.4B) |
| Earnings from Cont. Ops | (368.3M) | (123.5M) | (361.8M) | (246.7M) | (1.4B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (317.5M) | (121.1M) | (323.7M) | (255.8M) | (1.4B) |
| Per Share | |||||
| Basic EPS | (HK$0.50) | (HK$0.20) | (HK$0.51) | (HK$0.40) | (HK$12.19) |
| Diluted EPS | (HK$0.50) | (HK$0.20) | (HK$0.51) | (HK$0.40) | (HK$12.19) |
| Revenue Per Share | HK$5.59 | HK$3.35 | HK$7.14 | HK$7.32 | HK$5.40 |
| Shares | |||||
| Basic Shares Outstanding | 613.0M | 602.1M | 639.0M | 644.1M | 763.0M |
| Diluted Shares Outstanding | 613.0M | 602.1M | 639.0M | 644.1M | 763.0M |
| Profitability Metrics | |||||
| EBITDA | (228.0M) | (75.5M) | (259.5M) | (226.1M) | (1.3B) |
| D&A | 14.3M | 26.2M | 14.8M | 16.1M | 15.4M |
| EBIT | (242.3M) | (101.7M) | (274.4M) | (242.2M) | (633.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025